The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving Zafirlukast
Abstract
CONTEXT: Zafirlukast is a potent leukotriene antagonist that recently was approved for the treatment of asthma. As use of this drug increases, adverse events that occur at low frequency or in populations not studied in premarketing clinical trials may become evident. OBJECTIVE: To describe a clinical syndrome associated with zafirlukast therapy. DESIGN: Case series. PATIENTS: Eight adults (7 women and 1 man) with steroid-dependent asthma who received zafirlukast. MAIN OUTCOME MEASURES: Development of a clinical syndrome characterized by pulmonary infiltrates, cardiomyopathy, and eosinophilia following the withdrawal of corticosteroid treatment. RESULTS: The clinical syndrome developed while patients were receiving zafirlukast from 3 days to 4 months and from 3 days to 3 months after corticosteroid withdrawal. All 8 patients developed leukocytosis (range, 14.5-27.6 x 10(9)/L) with eosinophilia (range, 0.19-0.71). Six patients had fever (temperature >38.5 degrees C), 7 had muscle pain, 6 had sinusitis, and 6 had biopsy evidence of eosinophilic tissue infiltration. The clinical syndrome improved with discontinuation of zafirlukast treatment and reinitiation of corticosteroid treatment or addition of cyclophosphamide treatment. COMMENT: Development of pulmonary infiltrates, cardiomyopathy, and eosinophilia may have occurred independent of zafirlukast use or may have resulted from an allergic response to this medication. We suspect that these patients may have had a primary eosinophilic infiltrative disorder that had been clinically recognized as asthma, was quelled by steroid treatment, and was unmasked following corticosteroid withdrawal facilitated by zafirlukast.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,215
The idiopathic hypereosinophilic syndrome
Weller, P., & Bubley, G. (1994) · Blood · doi:10.1182/blood.v83.10.2759.2759 · Cited by 929
Spector, S. L., Smith, L. J., & Glass, M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.3.8087328 · Cited by 341
Epidemiology of systemic vasculitis: Changing incidence or definition?
Watts, R. A., Carruthers, D. M., & Scott, D. G. I. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80015-8 · Cited by 223
Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy
Holgate, S. T., Bradding, P., & Sampson, A. P. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70220-8 · Cited by 215
Suissa, S., Dennis, R., Ernst, P., Sheehy, O., & Wood-Dauphinee, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-3-199702010-00001 · Cited by 204
Formes Frustes of Churg-Strauss Syndrome
Churg, A., Brallas, M., Cronin, S. R., & Churg, J. (1995) · Chest · doi:10.1378/chest.108.2.320 · Cited by 166
Tai, P. C., Holt, M. E., Denny, P., Gibbs, A. R., Williams, B. D., & Spry, C. J. F. (1984) · BMJ · doi:10.1136/bmj.289.6442.400 · Cited by 117
Vasculitis with allopurinol therapy
Jarzobski, J. A., Ferry, J., Wombolt, D. G., Fitch, D. M., & Egan, J. D. (1970) · American Heart Journal · doi:10.1016/0002-8703(70)90401-1 · Cited by 75
Carbamazepine-Induced Granulomatous Nectrotizing Angiitis with Acute Renal Failure
Imai, H., Nakamoto, Y., Hirokawa, M., AKIHAMA, T., & Miura, A. B. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185332 · Cited by 57
Cited by
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Sablé-Fourtassou, R., Cohen, P., Mahr, A., Pagnoux, C., Mouthon, L., Jayne, D., Blockmans, D., Cordier, J.-F., Delaval, P., Puechal, X., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00006 · Cited by 688
Noth, I., Strek, M. E., & Leff, A. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12518-4 · Cited by 527
Aspirin-induced asthma: Advances in pathogenesis and management
Szczeklik, A., & Stevenson, D. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70106-5 · Cited by 323
Metadata
- Authors
- Wechsler, M. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-02-11
- Volume
- 279
- Issue
- 6
- Pages
- 455
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2136773451
- Cited by
- 330
- References
- 11
- FWCI
- 26.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving Zafirlukast. https://app.cochat.ai/papers/10.1001/jama.279.6.455
- The paper
- Wechsler, M. E. (1998). Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving Zafirlukast. JAMA. https://doi.org/10.1001/jama.279.6.455
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.